www.brightscope.com/401k-rating/105123/Glaxosmithkline-Llc/106678/Gsk-401K-Plan

GSK 401k Plan is a defined contribution plan with a profit-sharing component, 401k feature, and ESOP component. This plan has a BrightScope Rating of 87, ...

www.myvisajobs.com/Visa-Sponsor/Glaxosmithkline/861599.htm

Glaxosmithkline Llc has filed 180 labor condition applications for H1B visa and 9 labor certifications for green card from fiscal year 2016 to 2018.

www.opensecrets.org/pacs/lookup2.php?strID=C00199703

FOREIGN PARENT COMPANY: GlaxoSmithKline. COUNTRY OF ORIGIN: UK Official PAC Name: GLAXOSMITHKLINE LLC PAC (GSK PAC) Location: RES.

www.patentdocs.org/2017/06/glaxosmithkline-llc-v-glenmark-pharmaceuticals-inc-d-del-2017.html

Jun 25, 2017 ... Earlier this month, in GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., U.S. District Judge Leonard P. Stark of the U.S. District Court for ...

www.drinkerbiddle.com/insights/publications/2018/08/dolin-v-glaxosmithkline-llc-decision

Aug 24, 2018 ... Chicago partner William Essig authored an analysis for Law360 titled “7th Cir. Focuses on Impossibility Preemption in Dolin v. GSK.”.

caselaw.findlaw.com/us-federal-circuit/1658181.html

Case opinion for US Federal Circuit GLAXOSMITHKLINE LLC v. Watson Laboratories, Inc. Florida, Defendant–Appellant.. Read the Court's full decision on ...

www.chamberlitigation.com/cases/dolin-v-glaxosmithkline-llc

Jan 29, 2018 ... U.S. Chamber argues that Illinois law does not recognize “innovator liability” theory for manufacturers of FDA approved.

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c57982f2-c7da-488a-7ea9-b9609439ac68

NDC Code(s): 0007-4139-20, 0007-4140-20, 0007-4141-20, 0007-4142-20; Packager: GlaxoSmithKline LLC. Category: HUMAN PRESCRIPTION DRUG ...

www.americanbar.org/content/dam/aba/publications/supreme_court_preview/briefs_2016_2017/16-466_amicus_pet_glaxo_smith_kline.pdf

Mar 8, 2017 ... Amicus curiae GlaxoSmithKline LLC (“GSK”) is a pharmaceutical company that researches and develops medicines, vaccines, and consumer.